HPGC Renmintongtai Pharmaceutical Corp (600829) — Financial Flexibility Index
HPGC Renmintongtai Pharmaceutical Corp (600829) has a Financial Flexibility Index of -0.04x as of September 2025. Free cash flow of CN¥-180.70 Million (operating CF CN¥-187.38 Million minus capex CN¥6.68 Million) represents 0% of total liabilities (CN¥4.03 Billion). Check 600829 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
HPGC Renmintongtai Pharmaceutical Corp Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for HPGC Renmintongtai Pharmaceutical Corp across 28 annual periods. For the full cash flow conversion analysis, see 600829 cash flow metrics.
Annual Financial Flexibility Index for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
Year-by-year free cash flow to debt coverage for HPGC Renmintongtai Pharmaceutical Corp. Explore 600829 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.08x | CN¥317.13 Million | CN¥299.98 Million | CN¥4.16 Billion | ▲ +164.6% |
| 2024 | 0.03x | CN¥123.48 Million | CN¥115.44 Million | CN¥4.29 Billion | ▼ -62.2% |
| 2023 | 0.08x | CN¥356.47 Million | CN¥332.99 Million | CN¥4.68 Billion | ▲ +11.7% |
| 2022 | 0.07x | CN¥313.75 Million | CN¥307.33 Million | CN¥4.60 Billion | ▲ +240.7% |
| 2021 | -0.05x | CN¥-220.76 Million | CN¥-233.00 Million | CN¥4.55 Billion | ▼ -4192.9% |
| 2020 | 0.00x | CN¥4.75 Million | CN¥-9.22 Million | CN¥4.00 Billion | ▲ +101.1% |
| 2019 | -0.11x | CN¥-403.27 Million | CN¥-411.60 Million | CN¥3.70 Billion | ▼ -182.9% |
| 2018 | 0.13x | CN¥372.19 Million | CN¥366.45 Million | CN¥2.83 Billion | ▲ +190.3% |
| 2017 | 0.05x | CN¥146.17 Million | CN¥139.07 Million | CN¥3.23 Billion | ▲ +108.0% |
| 2016 | 0.02x | CN¥68.82 Million | CN¥46.01 Million | CN¥3.16 Billion | ▼ -83.5% |
| 2015 | 0.13x | CN¥369.57 Million | CN¥333.99 Million | CN¥2.81 Billion | ▼ -63.8% |
| 2014 | 0.36x | CN¥409.64 Million | CN¥392.58 Million | CN¥1.13 Billion | ▲ +518.1% |
| 2013 | -0.09x | CN¥-125.31 Million | CN¥-158.31 Million | CN¥1.44 Billion | ▼ -160.1% |
| 2012 | 0.14x | CN¥252.13 Million | CN¥221.57 Million | CN¥1.75 Billion | ▲ +1751.3% |
| 2011 | -0.01x | CN¥-16.69 Million | CN¥-108.30 Million | CN¥1.91 Billion | ▼ -106.4% |
| 2010 | 0.14x | CN¥217.89 Million | CN¥162.99 Million | CN¥1.58 Billion | ▼ -69.5% |
| 2009 | 0.45x | CN¥541.18 Million | CN¥447.82 Million | CN¥1.20 Billion | ▲ +6465.7% |
| 2008 | 0.01x | CN¥8.72 Million | CN¥-65.93 Million | CN¥1.27 Billion | ▼ -96.2% |
| 2007 | 0.18x | CN¥233.86 Million | CN¥191.10 Million | CN¥1.27 Billion | ▼ -19.3% |
| 2006 | 0.23x | CN¥262.87 Million | CN¥191.13 Million | CN¥1.16 Billion | ▼ -28.1% |
| 2005 | 0.32x | CN¥348.00 Million | CN¥313.04 Million | CN¥1.10 Billion | ▲ +96.2% |
| 2004 | 0.16x | CN¥133.38 Million | CN¥60.69 Million | CN¥828.09 Million | ▼ -68.9% |
| 2003 | 0.52x | CN¥267.11 Million | CN¥71.65 Million | CN¥516.46 Million | ▲ +14.2% |
| 2002 | 0.45x | CN¥182.81 Million | CN¥127.49 Million | CN¥403.72 Million | ▲ +315.0% |
| 2001 | 0.11x | CN¥50.15 Million | CN¥14.79 Million | CN¥459.59 Million | ▼ -52.5% |
| 2000 | 0.23x | CN¥122.94 Million | CN¥61.85 Million | CN¥534.74 Million | ▼ -35.0% |
| 1999 | 0.35x | CN¥101.66 Million | CN¥58.21 Million | CN¥287.56 Million | ▲ +38.9% |
| 1998 | 0.25x | CN¥61.55 Million | CN¥41.00 Million | CN¥241.76 Million | — |